IL246913B - Methods for treating skin infection by administering an il-4r antagonist - Google Patents

Methods for treating skin infection by administering an il-4r antagonist

Info

Publication number
IL246913B
IL246913B IL246913A IL24691316A IL246913B IL 246913 B IL246913 B IL 246913B IL 246913 A IL246913 A IL 246913A IL 24691316 A IL24691316 A IL 24691316A IL 246913 B IL246913 B IL 246913B
Authority
IL
Israel
Prior art keywords
antagonist
administering
methods
treating skin
skin infection
Prior art date
Application number
IL246913A
Other languages
Hebrew (he)
Other versions
IL246913A0 (en
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2015/017834 external-priority patent/WO2015130975A1/en
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Publication of IL246913A0 publication Critical patent/IL246913A0/en
Publication of IL246913B publication Critical patent/IL246913B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
IL246913A 2014-02-28 2016-07-24 Methods for treating skin infection by administering an il-4r antagonist IL246913B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201461946237P 2014-02-28 2014-02-28
US201461952245P 2014-03-13 2014-03-13
US201461986371P 2014-04-30 2014-04-30
EP14306476 2014-09-24
US201562100128P 2015-01-06 2015-01-06
PCT/US2015/017834 WO2015130975A1 (en) 2014-02-28 2015-02-26 Methods for treating skin infection by administering an il-4r antagonist

Publications (2)

Publication Number Publication Date
IL246913A0 IL246913A0 (en) 2016-09-29
IL246913B true IL246913B (en) 2021-10-31

Family

ID=66624714

Family Applications (1)

Application Number Title Priority Date Filing Date
IL246913A IL246913B (en) 2014-02-28 2016-07-24 Methods for treating skin infection by administering an il-4r antagonist

Country Status (1)

Country Link
IL (1) IL246913B (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LIN, YU-TSAN; WANG, CHEN-TI; CHIANG, BOR-LUEN., AYOPIC DERMATITIS, 1 December 2007 (2007-12-01) *
PETRY, VANESSA, ET AL., SKIN COLONIZATION, 1 September 2012 (2012-09-01) *
WADE WATSON AND SANDEEP KAPUR, DERMATITIS, 10 November 2011 (2011-11-10) *

Also Published As

Publication number Publication date
IL246913A0 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
PL3110848T3 (en) Methods for treating skin infection by administering an il-4r antagonist
PT3613432T (en) Methods for treating nasal polyposis by administering an il-4r antagonist
HUE067888T2 (en) Methods for preventing or treating allergy by administering an il-4r antagonist
PL3107575T3 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
ZA201705673B (en) Methods for treating skin
ES3059021T3 (en) Patient interface
PT3154633T (en) System for fast ultrasound treatment
GB201701673D0 (en) Methods of well treatment
EP3157601A4 (en) Patient interface for respiratory therapy
IL240326A0 (en) System for glaucoma treatment
EP3104807B8 (en) Device for teeth treatment
SG11201703928QA (en) Patient interface
AU358462S (en) Patient interface
GB201403104D0 (en) Skin treatment device
PL3215219T3 (en) Skin treatment system
PT3020430T (en) Cannula for catgut-embedding therapy
EP3226899A4 (en) Methods for treating dry eye disease by administering an il-6r antagonist
GB201510676D0 (en) Novel diagnostic and therapeutic method
SG10201912898XA (en) Methods for treating nasal polyposis by administering an il-4r antagonist
SG11201700059WA (en) Therapeutic agent for keratoconjunctive disorder
GB201409603D0 (en) An inhalable medicament
IL246913A0 (en) Methods for treating skin infection by administering an il-4r antagonist
GB201401806D0 (en) Novel methods for diagnosis and therapy
IL247290A0 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
CA3249780A1 (en) Methods for treating or preventing asthma by administering an il-4r antagonist